SCHEMBL3569662

SCHEMBL3569662

CCNc1nc(CC)ccc1C(N)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.55
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
SYK P43405 1/20 0.39
JAK2 O60674 1/20 0.38
JAK3 P52333 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
RPS6KB1 P23443 2/20 0.35
PGK1 P00558 1/20 0.35
MAPK8 P45983 3/20 0.35
NNMT P40261 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23009954 0.81 KDM4E (0.43) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL4540580 0.78 MAPK8 (0.50) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL14917467 0.76 PARP1 (0.57) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL440740 0.76 PARP1 (0.57) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL30028472 0.76 PARP1 (0.57) PARP1KDM4EALDH1A1NNMTGABRP
Hydrochloric Acid SCHEMBL29152372 0.75 PARP1 (0.55) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL8198347 0.74 TSHR (0.41) PARP1KDM4EALDH1A1HPGD
SCHEMBL8198909 0.74 POLB (0.45) PARP1KDM4EALDH1A1HPGD
SCHEMBL7456419 0.73 PARP1 (0.50) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL8185074 0.73 VNN1 (0.41) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US disclosed
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds AADAT, AAAS, AADAC PARP1 797/4885KDM4E 1828/4885ALDH1A1 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.